Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02950961 · ClinicalTrials.gov registry record · NA
Collaborative Care for Women Veterans
A NA study of Depression and Anxiety, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 153
- Enrollment target
- 3
- Study locations
NCT02950961: Completed NA study of Depression and Anxiety, sponsored by VA Office of Research and Development.
NCT02950961 is a NA study of Depression and Anxiety that has completed, run by VA Office of Research and Development. The registered enrollment target is 153 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02950961, a NA study of Depression and Anxiety, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
- 3
- Study locations
Study Summary
Implementation of Tailored Collaborative Care for Women Veterans (CCWV) was designed to enhance primary care-mental health integration for women Veterans by tailoring services to women Veterans' and providers' needs and providing an evidence-based intervention, Coordinated Anxiety Learning and Management, to address anxiety and depression in a patient-centered approach. CCWV was implemented in two of the Women's Health Practice-Based Research Network sites, with careful attention to local tailoring and adaptation to enhance the fit of the care model in varied local contexts.
Primary Outcome
Change in utilization of services comparing utilization 30 days prior to 30 days post initiation of care with the care manager.
Conditions Studied
Interventions
- BEHAVIORAL Collaborative Care for Women Veterans
Study Locations (3)
California
- VA San Diego Healthcare System, San Diego, CA - San Diego
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles
Oregon
- VA Portland Health Care System, Portland, OR - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2017-06-30 |
| Est. Completion | 2021-03-08 |
| Phase | NA |
What the finished NCT02950961 record still lists
NCT02950961 is an interventional study that assigns participants to a tested intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Collaborative Care for Women Veterans is the first listed.
NCT02950961 reports a single indexed study location in California, Oregon.
Frequently Asked Questions
What is clinical trial NCT02950961 about?
NCT02950961 is a clinical study titled "Collaborative Care for Women Veterans". Implementation of Tailored Collaborative Care for Women Veterans (CCWV) was designed to enhance primary care-mental health integration for women Veterans by tailoring services to women Veterans' and providers' needs and providing an evidence-based intervention, Coordinated Anxiety Learning and Manag...
What is the current status of trial NCT02950961?
This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2017-06-30. Estimated completion is 2021-03-08.
What conditions does trial NCT02950961 study?
This clinical trial studies the following conditions: Depression, Anxiety, Stress Disorders, Post-Traumatic.
What interventions are being tested in trial NCT02950961?
The interventions under investigation include: Collaborative Care for Women Veterans (BEHAVIORAL).
Who is sponsoring clinical trial NCT02950961?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02950961 being conducted?
This trial has 3 study locations across California, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02950961's enrollment target sits among peer trials
153 247th of 679 higher than 433 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05584501 · 153 participants · NA
ETE Interventions in the Dental Setting
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy